Mélanie Flaender

Research, Development Scientist & Project Manager Cytoo

Seminars

Wednesday 1st October 2025
MyoScreen™: Leading the Discovery of Innovative Skeletal Muscle-Targeting Drugs for Healthy Weight Loss
2:30 pm
  • Highlighting novel platforms to identify muscle-preserving therapies for obesity
  • Addressing sarcopenia risks during weight loss with targeted drug discovery
  • Demonstrating preclinical-to-clinical translation of muscle-centric metabolic interventions
Mélanie Flaender